Evaluation of Anxiety Levels in Patients Undergoing Intravitreal Injections and Associated Risk Factors Related to the Disease
Purpose. To analyze patients’ anxiety levels using the Visual Analog Scale for Anxiety (VASA), in regard to intravitreal injection treatment and to determine possible associated risk factors related to the disease and treatment characteristics. Methods. Cross-sectional observational study with conse...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2020/4375390 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850223114795876352 |
|---|---|
| author | Juan-Carlos Herranz-Heras Almudena de-Pablo-Cabrera Beatriz Alonso-Martín Beatriz de-Lucas-Viejo Marta de-Castro-Liébana Enrique Mencía-Gutiérrez Manuel-Jesús Ferro-Osuna Carmen Romero Javier Sambricio |
| author_facet | Juan-Carlos Herranz-Heras Almudena de-Pablo-Cabrera Beatriz Alonso-Martín Beatriz de-Lucas-Viejo Marta de-Castro-Liébana Enrique Mencía-Gutiérrez Manuel-Jesús Ferro-Osuna Carmen Romero Javier Sambricio |
| author_sort | Juan-Carlos Herranz-Heras |
| collection | DOAJ |
| description | Purpose. To analyze patients’ anxiety levels using the Visual Analog Scale for Anxiety (VASA), in regard to intravitreal injection treatment and to determine possible associated risk factors related to the disease and treatment characteristics. Methods. Cross-sectional observational study with consecutive sampling of patients who were going to receive an intravitreal injection. Subjects completed the VASA prior to the procedure, and afterwards, their data were collected from the electronic medical history. Analysis was performed through a linear regression model. Results. Fifty-five men and forty-seven women were enrolled. The mean age was 73.9 ± 12.4 years (mean ± standard deviation (SD)), and the mean ± SD of previous injections was 12.8 ± 12. The most frequent pathologies found were age-related macular degeneration with 46.1% and diabetic macular edema with 36.3%. The median of anxiety levels measured in millimeters (mm) was 16 (interquartile range: 0–48). In univariate models, women presented a mean of 10.8 mm of anxiety more than men (p=0.03). The adjusted multivariate analysis demonstrated that younger patients declared higher anxiety levels (p=0.036). No significant association was found between the best corrected visual acuity (BCVA) on the day of the injection, the change in BCVA since the beginning of the treatment or the number of injections received, and the registered anxiety levels. Conclusions. Sex and age may have an influence on anxiety levels. BCVA and the number ofinjections received did not seem to have an influence on our patients anxiety levels. |
| format | Article |
| id | doaj-art-6ac5d1d03e58497095acb1d4a75e205e |
| institution | OA Journals |
| issn | 2090-004X 2090-0058 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Ophthalmology |
| spelling | doaj-art-6ac5d1d03e58497095acb1d4a75e205e2025-08-20T02:06:04ZengWileyJournal of Ophthalmology2090-004X2090-00582020-01-01202010.1155/2020/43753904375390Evaluation of Anxiety Levels in Patients Undergoing Intravitreal Injections and Associated Risk Factors Related to the DiseaseJuan-Carlos Herranz-Heras0Almudena de-Pablo-Cabrera1Beatriz Alonso-Martín2Beatriz de-Lucas-Viejo3Marta de-Castro-Liébana4Enrique Mencía-Gutiérrez5Manuel-Jesús Ferro-Osuna6Carmen Romero7Javier Sambricio8Ophthalmology Department, 12 de Octubre Hospital, Complutense University, Madrid 28041, SpainOphthalmology Department, 12 de Octubre Hospital, Complutense University, Madrid 28041, SpainOphthalmology Department, 12 de Octubre Hospital, Complutense University, Madrid 28041, SpainOphthalmology Department, 12 de Octubre Hospital, Complutense University, Madrid 28041, SpainOphthalmology Department, 12 de Octubre Hospital, Complutense University, Madrid 28041, SpainOphthalmology Department, 12 de Octubre Hospital, Complutense University, Madrid 28041, SpainOphthalmology Department, 12 de Octubre Hospital, Complutense University, Madrid 28041, SpainBiostatistical Research Institute (i + 12), 12 de Octubre Hospital, Complutense University, Madrid 28041, SpainOphthalmology Department, 12 de Octubre Hospital, Complutense University, Madrid 28041, SpainPurpose. To analyze patients’ anxiety levels using the Visual Analog Scale for Anxiety (VASA), in regard to intravitreal injection treatment and to determine possible associated risk factors related to the disease and treatment characteristics. Methods. Cross-sectional observational study with consecutive sampling of patients who were going to receive an intravitreal injection. Subjects completed the VASA prior to the procedure, and afterwards, their data were collected from the electronic medical history. Analysis was performed through a linear regression model. Results. Fifty-five men and forty-seven women were enrolled. The mean age was 73.9 ± 12.4 years (mean ± standard deviation (SD)), and the mean ± SD of previous injections was 12.8 ± 12. The most frequent pathologies found were age-related macular degeneration with 46.1% and diabetic macular edema with 36.3%. The median of anxiety levels measured in millimeters (mm) was 16 (interquartile range: 0–48). In univariate models, women presented a mean of 10.8 mm of anxiety more than men (p=0.03). The adjusted multivariate analysis demonstrated that younger patients declared higher anxiety levels (p=0.036). No significant association was found between the best corrected visual acuity (BCVA) on the day of the injection, the change in BCVA since the beginning of the treatment or the number of injections received, and the registered anxiety levels. Conclusions. Sex and age may have an influence on anxiety levels. BCVA and the number ofinjections received did not seem to have an influence on our patients anxiety levels.http://dx.doi.org/10.1155/2020/4375390 |
| spellingShingle | Juan-Carlos Herranz-Heras Almudena de-Pablo-Cabrera Beatriz Alonso-Martín Beatriz de-Lucas-Viejo Marta de-Castro-Liébana Enrique Mencía-Gutiérrez Manuel-Jesús Ferro-Osuna Carmen Romero Javier Sambricio Evaluation of Anxiety Levels in Patients Undergoing Intravitreal Injections and Associated Risk Factors Related to the Disease Journal of Ophthalmology |
| title | Evaluation of Anxiety Levels in Patients Undergoing Intravitreal Injections and Associated Risk Factors Related to the Disease |
| title_full | Evaluation of Anxiety Levels in Patients Undergoing Intravitreal Injections and Associated Risk Factors Related to the Disease |
| title_fullStr | Evaluation of Anxiety Levels in Patients Undergoing Intravitreal Injections and Associated Risk Factors Related to the Disease |
| title_full_unstemmed | Evaluation of Anxiety Levels in Patients Undergoing Intravitreal Injections and Associated Risk Factors Related to the Disease |
| title_short | Evaluation of Anxiety Levels in Patients Undergoing Intravitreal Injections and Associated Risk Factors Related to the Disease |
| title_sort | evaluation of anxiety levels in patients undergoing intravitreal injections and associated risk factors related to the disease |
| url | http://dx.doi.org/10.1155/2020/4375390 |
| work_keys_str_mv | AT juancarlosherranzheras evaluationofanxietylevelsinpatientsundergoingintravitrealinjectionsandassociatedriskfactorsrelatedtothedisease AT almudenadepablocabrera evaluationofanxietylevelsinpatientsundergoingintravitrealinjectionsandassociatedriskfactorsrelatedtothedisease AT beatrizalonsomartin evaluationofanxietylevelsinpatientsundergoingintravitrealinjectionsandassociatedriskfactorsrelatedtothedisease AT beatrizdelucasviejo evaluationofanxietylevelsinpatientsundergoingintravitrealinjectionsandassociatedriskfactorsrelatedtothedisease AT martadecastroliebana evaluationofanxietylevelsinpatientsundergoingintravitrealinjectionsandassociatedriskfactorsrelatedtothedisease AT enriquemenciagutierrez evaluationofanxietylevelsinpatientsundergoingintravitrealinjectionsandassociatedriskfactorsrelatedtothedisease AT manueljesusferroosuna evaluationofanxietylevelsinpatientsundergoingintravitrealinjectionsandassociatedriskfactorsrelatedtothedisease AT carmenromero evaluationofanxietylevelsinpatientsundergoingintravitrealinjectionsandassociatedriskfactorsrelatedtothedisease AT javiersambricio evaluationofanxietylevelsinpatientsundergoingintravitrealinjectionsandassociatedriskfactorsrelatedtothedisease |